Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3', 5'-monophosphate elevation in vascular smooth muscle cells

Endocrinology

Volumn 136, Issue 5, 1995, Pages 2135-2142

  Marumo, Takeshi ^a   Nakaki, Toshio ^a   Hishikawa, Kexichi ^a   Hirahashi, Junichi ^a   Suzuki, Hiromichi ^a   Kato, Ryuichi ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; ARGININE; ATRIAL NATRIURETIC FACTOR ALPHA; BACTERIUM LIPOPOLYSACCHARIDE; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; DIMETHYL SULFOXIDE; ENZYME INHIBITOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KT 5823; MESSENGER RNA; N(G) METHYLARGININE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; ZAPRINAST;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

AMINO ACID OXIDOREDUCTASES; ANIMAL; ANTIHYPERTENSIVE AGENTS; AORTA; ARGININE; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HUMAN; INTERLEUKIN-1; KINETICS; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, C-TYPE; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROTEINS; RATS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0028921778     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.136.5.7536663     Document Type: Article

References (45)

1. Drewett JG, Garbers DL 1994 The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15:135-162
2. Wilkins MR, Nunez DJ, Wharton J 1993 The natriuretic peptide family: turning hormones into drugs. J Endocrinol 137:347-359
3. Sudoh T, Minamino N, Kangawa K, Matsuo H 1990 C-Type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168: 863-870
4. Stingo AJ, Clavell AL, Aarhus LL, Burnett Jr JC 1992 Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 262:H308-H312
5. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H 1992 Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-/). J Clin Invest 90:1145-1149
6. Moncada S, Palmer RMJ, Higgs EA 1991 Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
7. Garg UC, Hassid A 1989 Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777
8. Nakaki T, Nakayama M, Kato R 1990 Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 189:347-353
9. Nathan C, Xie QW 1994 Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728
10. Morris Jr. SM, Billiar TR 1994 New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829-E839
11. Verbeuren TJ, Bonhomme E, Laubie M, Simonet S 1993 Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol 21:841-845
12. Joly GA, Schini VB, Vanhoutte PM 1992 Balloon injury and inter-leukin-lbeta induce nitric oxide synthase activity in rat carotid arteries. Circ Res 71:331-338
13. Douglas SA, Vickeryclark LM, Ohlstein EH 1994 Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction. Eur J Pharmacol 255:81-89
14. Nakaki T, Nakayama M, Yamamoto S, Kato R 1989 Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun 158:880-883
15. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 37:30-36
16. Nakaki T, Otsuka Y, Nakayama M, Kato R 1992 Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur J Pharmacol 219:311-318
17. Marumo T, Nakaki T, Suzuki H, Saruta T, Kato R 1993 Differential effects of bacterial lipopolysaccharide on interleukin-1 fi- and tumor necrosis factor-a-induced production of nitrite/nitrate in vascular smooth muscle cells. Pharmacol Commun 3:193-200
18. 15N]nitrate in biological fluids. Anal Biochem 126:131-138
19. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, Saruta T, Kato R 1992 Effect of systemic L-arginine administration on haemodynamics and nitric oxide release in man. Jpn Heart J 33:41-48
20. Gough NM 1988 Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173:93-95
21. Marumo T, Nakaki T, Nagata K, Miyata M, Adachi H, Esumi H, Suzuki H, Saruta T, Kato R 1993 Dexamethasone inhibits nitric oxide synthase mRNA induction by interleukin-1 alpha and tumor necrosis factor-alpha in vascular smooth muscle cells. Jpn J Pharmacol 63:361-367
22. 2+/calmodulin-dependent NO synthase in various organs of rats by Propionibacterium acnes and lipopolysaccharide treatment. FEBS Lett 308:22-25
23. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, Imura H 1992 Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 71:34-39
24. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Taka-hashi M, Murakata C, Sato A, Kaneko M 1987 K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436-440
25. Nakanishi S 1989 K-252 derivatives-K-252a, K-252b, KT5720, KT5926, KT5823. Seitaino-Kagaku 40:364-365 (in Japanese)
26. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inoue K, Imura H 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239
27. Lincoln TM, Cornwell TL 1993 Intracellular cyclic GMP receptor proteins. FASEB J 7:328-338
28. Wyatt TA, Pryzwansky KB, Lincoln TM 1991 KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res Commun Chem Pathol Pharmacol 74:3-14
29. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M 1994 Angiotensin-II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 269:11628-11633
30. Hortelano S, Genaro AM, Bosca L 1992 Phorbol esters induce nitric oxide synthase activity in rat hepatocytes-antagonism with the induction elicited by lipopolysaccharide. J Biol Chem 267:24937-24940
31. Hortelano S, Genaro AM, Bosca L1993 Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages. FEBS Lett 320:135-139
32. Saeki T, Saito 11993 Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta. Biochem Pharmacol 46:833-839
33. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M 1993 Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells-synergism with the induction elicited by inflammatory cytokines. J Biol Chem 268: 24959-24966
34. Gross SS, Levi R 1992 Tetrahydrobiopterin synthesis-an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267:25722-25729
35. Peunova N, Enikolopov G 1993 Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 364: 450-453
36. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ 1993 Macrophage nitric oxide synthase gene-two upstream regions mediate induction by interferongamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734
37. Xie QW, Whisnant R, Nathan C 1993 Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers induc-ibility by interferon-gamma and bacterial lipopolysaccharide. J Exp Med 177:1779-1784
38. Durante W, Cheng K, Schafer AI 1994 Cyclic nucleotide regulation of interleukin-1 beta induced nitric oxide synthase expression in vascular smooth muscle cells. Thromb Res 75:63-71
39. Garcia WA, Schneiderman JS, Baly DL 1990 Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1 beta and IL-1 alpha. FEBS Lett 269: 421-424
40. Beasley D, Schwartz JH, Brenner BM 1991 Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 87:602-608
41. Kanno K, Hirata Y, Imai T, Marumo F1993 Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 22:34-39
42. Beasley D, Eldridge M 1994 Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 266:R1197-R1203
43. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K 1993 Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells: evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 133:3038-3041
44. Moyer CF, Sajuthi D, Tulli H, Williams JK 1991 Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol 138:951-960
45. Barath P, Fishbein M, Cao J, Berenson J, Helfant R, Forrester J1990 Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 137:503-509